Yunnan Botanee Bio-Technology GroupLTD Management
Management criteria checks 3/4
Yunnan Botanee Bio-Technology GroupLTD's CEO is Kevin Guo, appointed in Mar 2019, has a tenure of 6.58 years. directly owns 2.62% of the company’s shares, worth CN¥495.59M. The average tenure of the management team and the board of directors is 2.5 years and 6.6 years respectively.
Key information
Kevin Guo
Chief executive officer
CN¥4.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.6yrs |
| CEO ownership | 2.6% |
| Management average tenure | 2.5yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
Here's Why Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Can Manage Its Debt Responsibly
Mar 11
Fewer Investors Than Expected Jumping On Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)
Jan 01Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders
Nov 02Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?
Oct 19The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More
Sep 27Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?
Sep 25Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year
Jun 03A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)
May 24Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 02Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet
Feb 29CEO
Kevin Guo (62 yo)
Mr. Zhenyu Guo, also known as Kevin serves as General Manager & Non-Independent Chairman of the Board at Yunnan Botanee Bio-Technology Group Co LTD since March 6, 2019.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Chairman of the Board | 6.6yrs | CN¥4.04m | 2.62% CN¥ 495.6m | |
| Deputy GM | 6.6yrs | CN¥2.82m | no data | |
| Senior Deputy GM & Director | 1.5yrs | CN¥3.12m | no data | |
| Senior Deputy GM & Non-Independent Director | 1.5yrs | CN¥3.81m | no data | |
| Deputy GM & Director | 2.4yrs | CN¥2.49m | no data | |
| Deputy General Manager | 2.7yrs | CN¥2.80m | no data | |
| Head of Accounting Department & Accounting Supervisor | no data | no data | no data |
Experienced Management: 300957's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Chairman of the Board | 6.6yrs | CN¥4.04m | 2.62% CN¥ 495.6m | |
| Senior Deputy GM & Director | 6.6yrs | CN¥3.12m | no data | |
| Senior Deputy GM & Non-Independent Director | 6.6yrs | CN¥3.81m | no data | |
| Deputy GM & Director | 2.4yrs | CN¥2.49m | no data | |
| Non-Independent Director | 6.6yrs | no data | no data | |
| Non-Independent Director | 6.6yrs | CN¥600.00k | no data | |
| Independent Non-Executive Director | 6.6yrs | CN¥200.00k | no data | |
| Independent Non-Executive Director | 6.6yrs | CN¥200.00k | no data | |
| Chairman of the Supervisory Board | 6.6yrs | no data | no data | |
| Independent Director | 1.1yrs | CN¥57.00k | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
Experienced Board: 300957's board of directors are considered experienced (6.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/07 22:56 |
| End of Day Share Price | 2025/09/30 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yunnan Botanee Bio-Technology Group Co.LTD is covered by 31 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiyue Zhang | Chasing Securities |
| Zhuonan Xu | China International Capital Corporation Limited |
| Li Liu | China Merchants Securities (HK) Co., Ltd |